SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Sold by Petra Financial Advisors Inc.

Petra Financial Advisors Inc. cut its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 5.2% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 8,540 shares of the exchange traded fund’s stock after selling 464 shares during the period. Petra Financial Advisors Inc.’s holdings in SPDR S&P Biotech ETF were worth $769,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in XBI. Healthcare of Ontario Pension Plan Trust Fund increased its position in shares of SPDR S&P Biotech ETF by 198.6% during the third quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 9,229,000 shares of the exchange traded fund’s stock valued at $911,825,000 after acquiring an additional 6,138,000 shares during the last quarter. Clal Insurance Enterprises Holdings Ltd acquired a new stake in shares of SPDR S&P Biotech ETF during the third quarter valued at about $141,284,000. Proficio Capital Partners LLC increased its position in shares of SPDR S&P Biotech ETF by 16,156.1% during the fourth quarter. Proficio Capital Partners LLC now owns 917,329 shares of the exchange traded fund’s stock valued at $82,615,000 after acquiring an additional 911,686 shares during the last quarter. Raymond James Financial Inc. purchased a new position in shares of SPDR S&P Biotech ETF in the fourth quarter valued at approximately $55,529,000. Finally, J.Safra Asset Management Corp boosted its stake in shares of SPDR S&P Biotech ETF by 461.6% in the fourth quarter. J.Safra Asset Management Corp now owns 292,502 shares of the exchange traded fund’s stock valued at $26,293,000 after purchasing an additional 240,415 shares during the period.

SPDR S&P Biotech ETF Stock Performance

NYSEARCA XBI opened at $88.29 on Tuesday. The firm has a 50 day simple moving average of $89.98 and a 200-day simple moving average of $94.69. SPDR S&P Biotech ETF has a one year low of $81.14 and a one year high of $105.47. The firm has a market cap of $5.72 billion, a price-to-earnings ratio of 11.47 and a beta of 0.99.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.